ADNI | Active Investigations

Select the area you would like to search.
ADNI SITE
DATA DICTIONARY This search queries the ADNI data dictionary. Enter terms or codes used in the dictionary for a definition, or enter search terms to locate data within the archive.
ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.

Active Investigations

There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.

Principal Investigator
Principal Investigator's Name:	Osamu Ichikawa
Institution:	SUMITOMO DAINIPPON PHARMA CO., LTD.
Department:	Platform Technology Research Unit
Country:
Proposed Analysis:	We would like to use ADNI data through DSS NIAGADS as NG00067.v5-ADSP Umbrella datasets. The project name is "Understanding the genetic mechanism of Alzheimer's Disease", and DAR ID is 10369. The purpose of our study is to identify effective therapeutic targets for Alzheimer’s disease. Alzheimer’s disease is heterogeneous disease, which result from different combinations of genetic factors as well as environmental factors. Stratifying this heterogeneous disorder into subtypes based on genetic factors and objective phenotypes is important step to discover effective therapeutic targets. The whole genome sequencing data and the whole exome sequencing data will be analyzed to identify novel genetic variants associated with disease and/or subtypes.
Additional Investigators
Investigator's Name:	Asako Komori
Proposed Analysis:	We would like to use ADNI data through DSS NIAGADS as NG00067.v5-ADSP Umbrella datasets. The project name is "Understanding the genetic mechanism of Alzheimer's Disease", and DAR ID is 10369. The purpose of our study is to identify effective therapeutic targets for Alzheimer’s disease. Alzheimer’s disease is heterogeneous disease, which result from different combinations of genetic factors as well as environmental factors. Stratifying this heterogeneous disorder into subtypes based on genetic factors and objective phenotypes is important step to discover effective therapeutic targets. The whole genome sequencing data and the whole exome sequencing data will be analyzed to identify novel genetic variants associated with disease and/or subtypes